Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-02 09:53 am Sale |
2023-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 0 0.000% |
-420,710 (Position Closed) |
Filing History |
| 2023-04-14 4:01 pm Purchase |
2023-04-04 | 13D | Cocrystal Pharma, Inc. COCP |
FROST PHILLIP MD | 1,332,608 13.100% |
1,332,608 (New Position) |
Filing History |
| 2023-04-12 4:09 pm Purchase |
2023-04-04 | 13G | Cocrystal Pharma, Inc. COCP |
HASSAN FRED | 1,015,229 10.000% |
1,015,229 (New Position) |
Filing History |
| 2023-01-10 11:40 am Sale |
2022-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 420,710 11.000% |
-57,467 (-12.02%) |
Filing History |
| 2022-02-10 3:49 pm Sale |
2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
Renaissance Technologies LLC | 158,577 1.950% |
-170,588 (-51.82%) |
Filing History |
| 2022-01-03 9:47 pm Sale |
2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 478,177 11.000% |
-333,490 (-41.09%) |
Filing History |
| 2021-06-09 5:44 pm Purchase |
2021-06-09 | 13D | Cocrystal Pharma, Inc. COCP |
FROST PHILLIP MD | 310,526 3.800% |
310,526 (New Position) |
Filing History |
| 2021-05-25 1:15 pm Unchanged |
2021-05-05 | 13D | Cocrystal Pharma, Inc. COCP |
FiveT Investment Management Ltd | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-05-17 5:13 pm Purchase |
2021-05-05 | 13G | Cocrystal Pharma, Inc. COCP |
Ayrton Capital LLC | 543,333 6.690% |
543,333 (New Position) |
Filing History |
| 2021-05-12 2:13 pm Purchase |
2021-05-05 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 811,667 11.000% |
811,667 (New Position) |
Filing History |
| 2021-02-16 09:46 am Sale |
2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
CVI Investments, Inc. | 0 0.000% |
-288,462 (Position Closed) |
Filing History |
| 2021-02-10 10:12 am Purchase |
2020-05-29 | 13G | Cocrystal Pharma, Inc. COCP |
Renaissance Technologies LLC | 329,165 5.760% |
329,165 (New Position) |
Filing History |
| 2021-01-05 09:26 am Sale |
2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 0 0.000% |
-288,462 (Position Closed) |
Filing History |
| 2020-11-19 4:01 pm Purchase |
2020-11-13 | 13D | Cocrystal Pharma, Inc. COCP |
OPKO HEALTH INC. OPK |
307,921 5.400% |
781 (+0.25%) |
Filing History |